Request for Single Patient IND for Compassionate/Emergency Use of Tocilizumab

Tocilizumab for Acute Chest Syndrome

NCT05640271 ·Status: RECRUITING ·Phase: PHASE2

Tocilizumab in Patients With Schnitzler's Syndrome

NCT03046381 ·Status: COMPLETED ·Phase: PHASE2

ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

NCT05233397 ·Status: RECRUITING ·Phase: PHASE2

Compassionate Use Protocol for the Treatment of Autoinflammatory Syndromes

NCT01724580 ·Status: APPROVED_FOR_MARKETING

Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).

NCT06751238 ·Status: RECRUITING ·Phase: PHASE1

Safety and Effectiveness of h5G1.1-mAb for Dermatomyositis

NCT00005571 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Tofacitinib for Chronic Granulomatous Disease With Inflammatory Complications

NCT05104723 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Tofacitinib Citrate Topical Gel 3.2% FDA BA Bridging Study

NCT04468425 ·Status: COMPLETED ·Phase: PHASE1

Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host Disease

NCT01475162 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Tocilizumab (TCZ) Administered to Participants With Giant Cell Arteritis (GCA).

NCT03923738 ·Status: COMPLETED ·Phase: PHASE1

Omalizumab to Treat Hyper-IgE (Job's) Syndrome

NCT00260702 ·Status: COMPLETED ·Phase: PHASE1

Novel Treatment for Syndromic Ichthyoses

NCT01110642 ·Status: WITHDRAWN ·Phase: PHASE2

Multi Center Prospective Registry of Infliximab Use for Childhood Uveitis

NCT00589628 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)

NCT06987539 ·Status: RECRUITING ·Phase: PHASE2

Abatacept in Juvenile Dermatomyositis

NCT02594735 ·Status: COMPLETED ·Phase: PHASE4

A Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy (DMD)

NCT06450639 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Ruxolitinib in Previously Treated Idiopathic Multicentric Castleman Disease

NCT07085039 ·Status: RECRUITING ·Phase: PHASE2

Xolair Interventional Study in ASD Patients With Comorbid Atopy

NCT04535817 ·Status: WITHDRAWN ·Phase: PHASE1

Itacitinib and Tocilizumab for Steroid Refractory Acute Graft Versus Host Disease

NCT04070781 ·Status: TERMINATED ·Phase: PHASE1

Safety, Tolerability and Efficacy of Evolocumab (AMG 145) in Children With Inherited Elevated Low-density Lipoprotein Cholesterol (Familial Hypercholesterolemia)

NCT02624869 ·Status: COMPLETED ·Phase: PHASE3

Study of Efficacy and Safety of Ruxolitinib in Patients With Grade II to IV Steroid-refractory Acute Graft vs. Host Disease

NCT06462469 ·Status: RECRUITING ·Phase: PHASE4

JAK/STAT Inhibition in CNS Kohlmeier-Degos Disease

NCT05998395 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of Xolair in Peanut-Allergic Subjects Previously Enrolled in Study Q2788g

NCT00382148 ·Status: COMPLETED ·Phase: PHASE2

Evaluate the Safety and Efficacy of Canakinumab in Pediatric Patients With Colchicine Intolerant or Colchicine Resistant Familial Mediterranean Fever (FMF)

NCT01148797 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis

NCT02245841 ·Status: COMPLETED ·Phase: PHASE4